Growth Metrics

Boston Scientific (BSX) Free Cash Flow (2016 - 2026)

Boston Scientific's Free Cash Flow history spans 18 years, with the latest figure at $171.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow fell 51.69% to $171.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.5 billion, a 15.3% increase, with the full-year FY2025 number at $3.7 billion, up 38.3% from a year prior.
  • Free Cash Flow hit $171.0 million in Q1 2026 for Boston Scientific, down from $1.0 billion in the prior quarter.
  • Over the last five years, Free Cash Flow for BSX hit a ceiling of $1.2 billion in Q4 2024 and a floor of -$179.0 million in Q1 2022.
  • Historically, Free Cash Flow has averaged $541.4 million across 5 years, with a median of $515.0 million in 2023.
  • Biggest five-year swings in Free Cash Flow: plummeted 185.65% in 2022 and later surged 2460.0% in 2025.
  • Tracing BSX's Free Cash Flow over 5 years: stood at $595.0 million in 2022, then increased by 15.97% to $690.0 million in 2023, then soared by 70.87% to $1.2 billion in 2024, then dropped by 14.08% to $1.0 billion in 2025, then plummeted by 83.12% to $171.0 million in 2026.
  • Business Quant data shows Free Cash Flow for BSX at $171.0 million in Q1 2026, $1.0 billion in Q4 2025, and $1.2 billion in Q3 2025.